European Society of Contraception Statement on Contraception in Obese Women

Gabriele S. Merki-Feld, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci, Regine Sitruk-Ware

Research output: Contribution to journalArticlepeer-review


The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

Original languageEnglish
Pages (from-to)19-28
Number of pages10
JournalEuropean Journal of Contraception and Reproductive Health Care
Issue number1
Publication statusPublished - Feb 1 2015


  • Contraceptive failure
  • Depo-medroxyprogesterone
  • Efficacy
  • Hormonal contraception
  • Obesity
  • Progestin-only contraception
  • Thromboembolic risk
  • Weight

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Pharmacology (medical)
  • Reproductive Medicine
  • Medicine(all)


Dive into the research topics of 'European Society of Contraception Statement on Contraception in Obese Women'. Together they form a unique fingerprint.

Cite this